Cancers arise in the body all the time. Most are nipped in the bud by the immune response, not least by its T cells, which detect telltale molecular markers—or antigens—on cancer cells and destroy them before they grow ...
Oct 24, 2012
0
0
An Inserm team in Dijon directed by François Ghiringhelli is to publish an article this week in the Nature Medicine review. The article suggests that two chemotherapy drugs frequently used to treat digestive and breast cancers ...
Dec 4, 2012
0
0
In a study published in the American Journal of Emergency Medicine, Mount Sinai researchers describe some of the earliest cases of a COVID-19-related illness newly identified by the U.S. Centers for Disease Control (CDC) ...
May 29, 2020
0
1
Micro-needles are a promising tool for the painless administration of vaccines through the skin. But, are these minuscule needles really effective? Ph.D. student Pim Schipper of the Leiden Academic Centre for Drug Research ...
Jun 20, 2019
0
0
The human immune system is remarkably efficient, but sometimes its attack is misdirected, leading to allergies, autoimmune diseases and rejection of transplant organs and therapeutic drugs. Current immune suppressants have ...
Jun 3, 2013
0
0
An innovation created by Purdue University researchers could improve therapy selection for personalized cancer care by helping specialists better identify the most effective drug treatment combinations for patients.
Aug 16, 2013
0
0
Medicines that are personally tailored to your DNA are becoming a reality, thanks to the work of U.S. and Chinese scientists who developed statistical models to predict which drug is best for a specific individual with a ...
Jul 16, 2013
0
0
Tumor necrosis factor—normally an infection-fighting substance produced by the body—can actually heighten susceptibility to tuberculosis if its levels are too high. University of Washington TB researchers unravel this ...
Apr 11, 2013
0
0
A new review paper titled "Senescent cell-derived vaccines: a new concept towards an immune response against cancer and aging?" has been published in Aging.
Jul 1, 2024
0
0
Researchers at the University of Cincinnati are testing a commonly used drug, called sirolimus, to determine its safety and efficacy in treating hospitalized patients with COVID-19 pneumonia in the trial.
Jul 15, 2020
0
3
